Related content

Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease

By Lokkegaard A.   Werdelin L.   Regeur L.   Karlsborg M.   Jensen S.   Brødsgaard E.   Madsen F.   Lonsdale M.   Friberg L.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 508-516

Springer Publishing Company

Access to resources Recommend Favorite

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson’s disease?: For

By Tatsch Klaus  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 29, Iss. 5, 2002-05 ,pp. : 711-714

Springer Publishing Company

Access to resources Recommend Favorite

SPECT imaging of D₂ dopamine receptors and endogenous dopamine release in mice

By Jongen Cynthia   Bruin Kora   Beekman Freek   Booij Jan  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 9, 2008-09 ,pp. : 1692-1698

Springer Publishing Company

Access to resources Recommend Favorite

Camptocormia and Parkinson's disease: MR imaging

By Bonneville Fabrice  

European Radiology, Vol. 18, Iss. 8, 2008-08 ,pp. : 1710-1719

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic value of asymmetric striatal D₂ receptor upregulation in Parkinson’s disease: an [¹²³I]IBZM and [¹²³I]FP-CIT SPECT study

By Verstappen C.   Bloem B.   Haaxma C.   Oyen W.   Horstink M.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 502-507

Springer Publishing Company

Access to resources Recommend Favorite